Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 240

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types

Open access
Hong, In-Sun · 2016 · Experimental & Molecular Medicine

Abstract

Granulocyte-macrophage colony-stimulating factor (GM-CSF, also called CSF-2) is best known for its critical role in immune modulation and hematopoiesis. A large body of experimental evidence indicates that GM-CSF, which is frequently upregulated in multiple types of human cancers, effectively marks cancer cells with a ‘danger flag’ for the immune system. In this context, most studies have focused on its function as an immunomodulator, namely its ability to stimulate dendritic cell (DC) maturation and monocyte/macrophage activity. However, recent studies have suggested that GM-CSF also promotes immune-independent tumor progression by supporting tumor microenvironments and stimulating tumor growth and metastasis. Although some studies have suggested that GM-CSF has inhibitory effects on tumor growth and metastasis, an even greater number of studies show that GM-CSF exerts stimulatory effects on tumor progression. In this review, we summarize a number of findings to provide the currently available information regarding the anticancer immune response of GM-CSG. We then discuss the potential roles of GM-CSF in the progression of multiple types of cancer to provide insights into some of the complexities of its clinical applications. More research is needed to understand the relationship between tumor progression and an immune-response-related protein. In-Sun Hong from South Korea ' s Gachon University, Incheon, reviewed recent research on “ granulocyte-macrophage colony-stimulating factor ” (GM-CSF), a protein that regulates the differentiation of stem cells in the bone marrow into immune cells. Clinical trials have shown that GM-CSF can be used to promote an immune response against some kinds of cancers, such as metastatic melanoma. However, there is growing evidence that cells unrelated to the immune system also produce GM-CSF, sometimes promoting tumor growth, such as in some skin and lung cancers, and at other times inhibiting it, such as in some colorectal cancers. More detailed knowledge of the interactions between GM-CSF and tumors is needed to improve clinical outcomes in the future.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/emm.2016.64

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 240

Metadata

Authors
Hong, I.-S.
Venue
Experimental & Molecular Medicine
Published
2016-07-01
Volume
48
Issue
7
Pages
e242-e242
ISSN
  • 1226-3613 (ISSN-L)
  • 2092-6413
OpenAlex
W2464604109
Cited by
240
References
3
FWCI
6.73
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.